Abstract CT223: Survival Prolongation by Rationale INnovative Genomics (SPRING): An international WIN Consortium Phase I/II proof-of-concept study to explore the safety and efficacy of a tri-therapy approach using avelumab, palbociclib and axitinib in advanced/metastatic non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates

2019 ◽  
Author(s):  
Benjamin Solomon ◽  
Enriqueta Felip ◽  
Jair Bar ◽  
Guy Berchem ◽  
Lyudmila Bazhenova ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Proof Of Concept ◽  
Small Cell Lung ◽  
Safety And Efficacy ◽  
Therapy Approach ◽  
Survival Prolongation

Phase I/II Trial of the Safety and Efficacy of AE-941 (Neovastat®) in the Treatment of Non–Small-Cell Lung Cancer

2003 ◽  
Vol 4 (4) ◽  
pp. 231-236 ◽  
Author(s):  
Jean Latreille ◽  
Gerald Batist ◽  
Francis Laberge ◽  
Pierre Champagne ◽  
Daniel Croteau ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Safety And Efficacy
Sign in / Sign up

Export Citation Format

Share Document